A Phase II Study of Coltuximab Ravtansine (SAR3419) Monotherapy in Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Hagop M. Kantarjian, Hervé Dombret, Jörge E. Cortes et al.|Clinical Lymphoma Myeloma & Leukemia|2015

Cited by 67